Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results from the TRA 2P-TIMI 50 Trial

Article Information

DOI 
http://dx.doi.org/10.1177/155989771204012
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2012 MD Conference Express®

Author Information

  1. Maria Vinall
  1. David A. Morrow, MD, MPH
    1. Brigham & Women's Hospital, Boston, Massachusetts, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
Jun 2015100
Jul 2015100
Aug 2015111
Sep 2015100
Oct 2015232
Nov 2015100
Total1343

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results from the TRA 2P-TIMI 50 Trial
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Thrombotic Disorders Clinical Trials